Schwab Charles Investment Management Inc. boosted its stake in shares of LifePoint Health Inc (NASDAQ:LPNT) by 7.8% during the third quarter, according to its most recent disclosure with the SEC. The institutional investor owned 148,762 shares of the company’s stock after purchasing an additional 10,757 shares during the period. Schwab Charles Investment Management Inc. owned about 0.38% of LifePoint Health worth $8,614,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds also recently made changes to their positions in the company. Zurcher Kantonalbank Zurich Cantonalbank grew its position in LifePoint Health by 10.8% during the second quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 1,678 shares of the company’s stock valued at $113,000 after purchasing an additional 164 shares in the last quarter. Shelton Capital Management purchased a new position in LifePoint Health during the second quarter valued at approximately $205,000. Capstone Investment Advisors Netherlands B.V. purchased a new position in LifePoint Health during the second quarter valued at approximately $233,000. Airain ltd purchased a new position in LifePoint Health during the second quarter valued at approximately $234,000. Finally, Commerce Bank purchased a new position in LifePoint Health during the second quarter valued at approximately $309,000. 99.18% of the stock is currently owned by hedge funds and other institutional investors.

Shares of LifePoint Health Inc (NASDAQ LPNT) opened at $49.80 on Tuesday. The company has a debt-to-equity ratio of 1.24, a current ratio of 1.85 and a quick ratio of 1.65. The stock has a market cap of $1,962.91, a P/E ratio of 11.77, a price-to-earnings-growth ratio of 1.30 and a beta of 0.67. LifePoint Health Inc has a one year low of $42.50 and a one year high of $70.95.

LifePoint Health (NASDAQ:LPNT) last issued its quarterly earnings data on Friday, October 27th. The company reported $0.80 earnings per share for the quarter, missing the Zacks’ consensus estimate of $0.95 by ($0.15). LifePoint Health had a return on equity of 7.01% and a net margin of 2.45%. The firm had revenue of $1.58 billion during the quarter, compared to analyst estimates of $1.60 billion. During the same quarter in the previous year, the firm posted $0.94 earnings per share. LifePoint Health’s quarterly revenue was down .7% compared to the same quarter last year. equities research analysts predict that LifePoint Health Inc will post 3.64 EPS for the current fiscal year.

LifePoint Health announced that its Board of Directors has authorized a share buyback program on Friday, October 27th that permits the company to repurchase $200.00 million in shares. This repurchase authorization permits the company to repurchase shares of its stock through open market purchases. Stock repurchase programs are usually a sign that the company’s management believes its shares are undervalued.

In other news, Director Marguerite Kondracke sold 3,416 shares of the business’s stock in a transaction on Tuesday, November 21st. The shares were sold at an average price of $43.80, for a total value of $149,620.80. Following the completion of the sale, the director now directly owns 17,479 shares in the company, valued at $765,580.20. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. 8.76% of the stock is currently owned by insiders.

A number of brokerages recently commented on LPNT. Mizuho set a $50.00 price objective on shares of LifePoint Health and gave the company a “hold” rating in a research report on Friday, October 27th. BidaskClub upgraded shares of LifePoint Health from a “strong sell” rating to a “sell” rating in a research note on Friday, December 15th. ValuEngine cut shares of LifePoint Health from a “buy” rating to a “hold” rating in a research note on Sunday. Credit Suisse Group assumed coverage on shares of LifePoint Health in a research note on Thursday, November 2nd. They issued a “neutral” rating and a $54.00 target price for the company. Finally, Zacks Investment Research cut shares of LifePoint Health from a “hold” rating to a “sell” rating in a research note on Tuesday, October 3rd. Two analysts have rated the stock with a sell rating, twelve have issued a hold rating and five have given a buy rating to the company’s stock. LifePoint Health currently has an average rating of “Hold” and an average target price of $60.23.

TRADEMARK VIOLATION WARNING: This piece was originally posted by The Cerbat Gem and is owned by of The Cerbat Gem. If you are accessing this piece on another domain, it was copied illegally and reposted in violation of United States & international copyright laws. The correct version of this piece can be read at https://www.thecerbatgem.com/2018/01/02/lifepoint-health-inc-lpnt-shares-bought-by-schwab-charles-investment-management-inc.html.

About LifePoint Health

LifePoint Health, Inc, through its subsidiaries, owns and operates community hospitals, regional health systems, physician practices, outpatient centers and post-acute facilities. As of December 31, 2016, the Company operated 72 hospital campuses in 22 states, having a total of 9,424 licensed beds. It offers a range of general and specialized healthcare services to patients through a network of hospitals and outpatient facilities.

Institutional Ownership by Quarter for LifePoint Health (NASDAQ:LPNT)

Receive News & Stock Ratings for LifePoint Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LifePoint Health and related stocks with our FREE daily email newsletter.